Primary open angle glaucoma (POAG) is a worldwide disease with intraocular pressure (IOP) being an important risk factor for the disease. Pharmacological and surgical treatments have been mainly targeted on lowering IOP by decreasing aqueous humor production or increasing aqueous humor outflow.
Stem cell therapy is a regenerative medicine technique consisting in
introducing new cells into a damaged tissue in order to restore it. In this paper we
present our multidisciplinary approach about the possible use of the Human
Mesenchymal Stem Cells in treating heart failure. A multidisciplinary team
composed by biologists, mathematicians, cardiologists and bioengineers was
selected in order to investigate the feasibility of repairing the necrotic tissue
damaged by myocardial infarction by means of Mesenchymal Stem Cells and to
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma
